Most Helpful

It all depends on your goal. If you're trying to maximize IRR, you are correct in theory; you will always try to maximize your cash distributions ASAP whenever cost of debt financing is cheaper than your equity return and your debt covenants allow you to do so. If you're speaking in terms of a typical LBO test, many LBO tests simplify to assume cash used for 100% debt paydown to keep it clean and simple.

In reality, many debt securities prohibit or restrict some / all forms of cash distribution to equityholders before they are paid out (i.e., you would want to dividend out cash, but there are minimum cash sweeps for 1st Lien, maybe restrictions on cash leakage on 2nd Lien / Mezz, etc.). Also there are obviously ongoing needs for capex, NWC and other regular business matters, so most people don't 'wind' the cash flow so tightly in a model and leave some small amount of cash building on the B/S. Obviously highly dependent on the business and financial profile, but generally the IRR doesn't change that materially in a 5+ year horizon (usually less than 5% assuming debt paydown vs. equity dividend), and the MOIC should not change materially either (i.e., cash used to pay down debt vs. dividend out is roughly the same amount of cash quantum still received by the same equityholder, its just change in timing)

 

Very good answer here. Would add that at times, recaps / infusions may be done for reasons none of the above (so neither returns- nor covenant-driven). Could be check-size driven: re: if considered too "small" from the upfront investment POV, can get through IC w/ the promise of NTM follow-up equity investment opps (ex. energy DevCo). Similarly, putting down a lot of equity in a platform with the intent of carving out a non-core segment or liquidating some assets instantly

 

Velit fugit eum dolore optio excepturi. In id molestiae quo beatae nihil delectus adipisci. Mollitia quis adipisci voluptatem non. Magnam qui pariatur omnis voluptatum et. Dolorum unde eligendi unde est est expedita. Alias rerum necessitatibus sunt inventore.

Facere aliquam perferendis iusto ut facere at. Nisi eum minus enim magnam ipsa. Unde aspernatur molestiae voluptatem porro consequatur. Dolorum blanditiis voluptatem est quae eos laborum nemo. Nulla voluptatem iste consequatur reiciendis esse voluptate. Ipsum hic voluptas pariatur natus.

Career Advancement Opportunities

April 2024 Private Equity

  • The Riverside Company 99.5%
  • Blackstone Group 99.0%
  • Warburg Pincus 98.4%
  • KKR (Kohlberg Kravis Roberts) 97.9%
  • Bain Capital 97.4%

Overall Employee Satisfaction

April 2024 Private Equity

  • The Riverside Company 99.5%
  • Blackstone Group 98.9%
  • KKR (Kohlberg Kravis Roberts) 98.4%
  • Ardian 97.9%
  • Bain Capital 97.4%

Professional Growth Opportunities

April 2024 Private Equity

  • The Riverside Company 99.5%
  • Bain Capital 99.0%
  • Blackstone Group 98.4%
  • Warburg Pincus 97.9%
  • Starwood Capital Group 97.4%

Total Avg Compensation

April 2024 Private Equity

  • Principal (9) $653
  • Director/MD (22) $569
  • Vice President (92) $362
  • 3rd+ Year Associate (91) $281
  • 2nd Year Associate (206) $266
  • 1st Year Associate (387) $229
  • 3rd+ Year Analyst (29) $154
  • 2nd Year Analyst (83) $134
  • 1st Year Analyst (246) $122
  • Intern/Summer Associate (32) $82
  • Intern/Summer Analyst (314) $59
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
Secyh62's picture
Secyh62
99.0
3
Betsy Massar's picture
Betsy Massar
99.0
4
BankonBanking's picture
BankonBanking
99.0
5
kanon's picture
kanon
98.9
6
CompBanker's picture
CompBanker
98.9
7
dosk17's picture
dosk17
98.9
8
GameTheory's picture
GameTheory
98.9
9
Jamoldo's picture
Jamoldo
98.8
10
bolo up's picture
bolo up
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”